Bradley Hargreaves
Chief Operating Officer presso XC Velle Institute, Inc.
Patrimonio netto: 160 256 $ in data 31/03/2024
Profilo
Bradley Hargreaves is currently the Operations Director & Principal at XC Velle Institute, Inc. and the Director, VP-Technology & Operations at Cell MedX (Canada) Corp.
He previously worked as the Director at Cell MedX Corp.
from 2023 to 2024.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CELL MEDX CORP.
1.81% | 07/02/2024 | 5 341 855 ( 1.81% ) | 160 256 $ | 31/03/2024 |
Posizioni attive di Bradley Hargreaves
| Società | Posizione | Inizio |
|---|---|---|
| XC Velle Institute, Inc. | Chief Operating Officer | 01/01/2009 |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Bradley Hargreaves
| Società | Posizione | Fine |
|---|---|---|
| CELL MEDX CORP. | Chief Tech/Sci/R&D Officer | 12/12/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELL MEDX CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
| XC Velle Institute, Inc. | |
Cell MedX (Canada) Corp.
Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Health Technology |
- Borsa valori
- Insiders
- Bradley Hargreaves
